Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2023	$ 160,362	$ 36	$ 754,971	$ (5)	$ (594,640)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2023		36,139,513
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	10,153	$ 1	10,152
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		1,061,336
Shares redeemed for employee tax withholdings, Amount	(2,134)		(2,134)
Shares redeemed for employee tax withholdings, Shares		(39,096)
Stock-based compensation expense	4,696		4,696
Unrealized loss on short-term investments and cash equivalents, net of tax	(45)			(45)
Foreign currency translation adjustment	(3)			(3)
Net Income (Loss)	(9,100)				(9,100)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2024	163,929	$ 37	767,685	(53)	(603,740)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2024		37,161,753
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2023	160,362	$ 36	754,971	(5)	(594,640)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2023		36,139,513
Net Income (Loss)	(15,179)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2024	275,207	$ 40	885,104	(118)	(609,819)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2024		39,617,334
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2024	163,929	$ 37	767,685	(53)	(603,740)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2024		37,161,753
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	3,103	$ 1	3,102
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		363,105
Stock-based compensation expense	6,105		6,105
Shares issued for the employee stock purchase plan, Amount	737		737
Shares issued for the employee stock purchase plan, Shares		38,905
Issuance of common stock for at-the-market offerings, net of issuance costs, Amount	107,477	$ 2	107,475
Issuance of common stock for at-the-market offerings, net of issuance costs, Shares		2,053,571
Unrealized loss on short-term investments and cash equivalents, net of tax	(64)			(64)
Foreign currency translation adjustment	(1)			(1)
Net Income (Loss)	(6,079)				(6,079)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2024	275,207	$ 40	885,104	(118)	(609,819)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2024		39,617,334
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2024	$ 281,238	$ 40	903,127	166	(622,095)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2024	40,428,220	40,428,220
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	$ 697	$ 1	696
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		210,332
Shares redeemed for employee tax withholdings, Amount	(1,418)		(1,418)
Shares redeemed for employee tax withholdings, Shares		(50,012)
Stock-based compensation expense	7,140		7,140
Unrealized loss on short-term investments and cash equivalents, net of tax	(157)			(157)
Foreign currency translation adjustment	6			6
Net Income (Loss)	(8,190)				(8,190)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2025	279,316	$ 41	909,545	15	(630,285)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2025		40,588,540
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2024	$ 281,238	$ 40	903,127	166	(622,095)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2024	40,428,220	40,428,220
Net Income (Loss)	$ (19,976)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2025	$ 278,012	$ 41	920,159	(117)	(642,071)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2025	40,913,380	40,913,380
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2025	$ 279,316	$ 41	909,545	15	(630,285)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2025		40,588,540
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	1,362		1,362
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		268,485
Stock-based compensation expense	8,547		8,547
Shares issued for the employee stock purchase plan, Amount	705		705
Shares issued for the employee stock purchase plan, Shares		56,355
Unrealized loss on short-term investments and cash equivalents, net of tax	(146)			(146)
Foreign currency translation adjustment	14			14
Net Income (Loss)	(11,786)				(11,786)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2025	$ 278,012	$ 41	$ 920,159	$ (117)	$ (642,071)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2025	40,913,380	40,913,380